Senate Generic Rx Bill Would Allow Challenges To “Orange Book” Listings
Executive Summary
The amended version of the McCain/Schumer generic drug legislation would allow generic companies to sue patent holders for not providing correct and complete information about "Orange Book" listings
You may also be interested in...
Senate Generic Reform Bill Likely To Result In Earlier ANDA Filings
A bipartisan Senate bill would encourage earlier ANDA filings by generics firms to head off new innovator patent listings and secure sole rights to 180-day exclusivity
Bush Generic Rx Proposal Has PhRMA Backing As Alternative To Legislation
The Pharmaceutical Research & Manufacturers of America is expected to endorse the Bush Administration's proposed generic drug reforms as an alternative to a Congressional reopening of Waxman/Hatch
Bush Generic Rx Proposal Has PhRMA Backing As Alternative To Legislation
The Pharmaceutical Research & Manufacturers of America is expected to endorse the Bush Administration's proposed generic drug reforms as an alternative to a Congressional reopening of Waxman/Hatch